Christopher Brooks
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Oncology top 0.5%
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
Papers in
- Oncology 50
- CAR-T cell therapy research 29
- Cancer-related Molecular Pathways 18
- Immunology 35
- Toxin Mechanisms and Immunotoxins 20
- Co-authors
- Wei Gu (13 shared papers)Muyang Li (6 shared papers)Wei Gu (5 shared papers)Ning Kon (3 shared papers)Jianyuan Luo (2 shared papers)Richard Baer (1 shared paper)Delin Chen (1 shared paper)Foon Wu-Baer (1 shared paper)
- Journals
- Blood (37 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (3 papers)Molecular Cell (2 papers)Cell Cycle (2 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Christopher Brooks
87 papers receiving 5.4k citations
Christopher Brooks's Hit Papers
Peers
Comparison fields: 5 of 111
- Geriatrics and Gerontology 371
- Oncology 2.8k
- Dermatology 424
- Molecular Biology 3.5k
- Cancer Research 626
Countries citing papers authored by Christopher Brooks
This map shows the geographic impact of Christopher Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Brooks more than expected).
Fields of papers citing papers by Christopher Brooks
This network shows the impact of papers produced by Christopher Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Brooks. The network helps show where Christopher Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | p53 Ubiquitination: Mdm2 and Beyond Hit paper breakdown → | 2006 | 717 |
| 2 | Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2 Hit paper breakdown → | 2003 | 626 |
| 3 | Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation Hit paper breakdown → | 2003 | 622 |
| 4 | A Dynamic Role of HAUSP in the p53-Mdm2 Pathway Hit paper breakdown → | 2004 | 528 |
| 5 | 2002 | 416 | |
| 6 | 2008 | 363 | |
| 7 | 2019 | 259 | |
| 8 | 2011 | 233 | |
| 9 | 2014 | 180 | |
| 10 | 2011 | 156 | |
| 11 | 2009 | 149 | |
| 12 | 2007 | 121 | |
| 13 | 2010 | 87 | |
| 14 | 2022 | 87 | |
| 15 | 2004 | 67 | |
| 16 | 2007 | 65 | |
| 17 | 2019 | 57 | |
| 18 | 2004 | 43 | |
| 19 | 2017 | 40 | |
| 20 | 2022 | 37 |
About Christopher Brooks
Christopher Brooks is a scholar working on Oncology, Immunology, Hematology, Molecular Biology and Genetics, having authored 87 papers that have together received 5.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (29 papers), Toxin Mechanisms and Immunotoxins (20 papers), Cancer-related Molecular Pathways (18 papers), Cutaneous lymphoproliferative disorders research (14 papers), Ubiquitin and proteasome pathways (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Acute Myeloid Leukemia Research (11 papers) and Chronic Lymphocytic Leukemia Research (11 papers). The work is most often cited by research in Geriatrics and Gerontology (371 citations), Oncology (2.8k citations), Dermatology (424 citations), Molecular Biology (3.5k citations) and Cancer Research (626 citations). Christopher Brooks has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Wei Gu, Muyang Li, Wei Gu, Ning Kon, Jianyuan Luo, Richard Baer, Delin Chen, Foon Wu-Baer, M Li and Marina Konopleva. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Molecular Cell and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.